Medipharm Labs Corp Stock Today
| MEDIF Stock | USD 0.05 0 3.85% |
Performance1 of 100
| Odds Of DistressLess than 32
|
Medipharm Labs is trading at 0.05 as of the 23rd of November 2024. This is a 3.85% down since the beginning of the trading day. The stock's lowest day price was 0.0464. Medipharm Labs has about a 32 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Medipharm Labs Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of September 2024 and ending today, the 23rd of November 2024. Click here to learn more.
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. The company has 280.51 M outstanding shares. More on Medipharm Labs Corp
Moving against Medipharm OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medipharm OTC Stock Highlights
| President Director | Keith Strachan |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Medipharm Labs Corp [MEDIF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medipharm Labs's market, we take the total number of its shares issued and multiply it by Medipharm Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medipharm Labs Corp classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 280.51 M outstanding shares.
Medipharm Labs Corp has accumulated about 21.99 M in cash with (13.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Medipharm Labs Probability Of Bankruptcy
Ownership AllocationMedipharm Labs Corp maintains a total of 280.51 Million outstanding shares. Medipharm Labs Corp secures 3.92 % of its outstanding shares held by insiders and 7.05 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medipharm Ownership Details
Medipharm Labs Corp Risk Profiles
| Mean Deviation | 2.85 | |||
| Semi Deviation | 3.49 | |||
| Standard Deviation | 4.1 | |||
| Variance | 16.79 |
Medipharm Stock Against Markets
Picking the right benchmark for Medipharm Labs otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Medipharm Labs otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Medipharm Labs is critical whether you are bullish or bearish towards Medipharm Labs Corp at a given time. Please also check how Medipharm Labs' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medipharm Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Medipharm Labs Corporate Management
Elected by the shareholders, the Medipharm Labs' board of directors comprises two types of representatives: Medipharm Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medipharm. The board's role is to monitor Medipharm Labs' management team and ensure that shareholders' interests are well served. Medipharm Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medipharm Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Greg Hunter | Chief Officer | Profile | |
| Saravan Subramaniam | VP Chain | Profile | |
| Nigel Dewsbury | Head Quality | Profile | |
| Geoffrey Marr | Exec Counsel | Profile | |
| Patrick McCutcheon | Founder | Profile | |
| Brett Moon | VP Sales | Profile |
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.